title: [Effect of lipid-bound apoA-I cysteine mutants upon lipopolysaccharide-induced endotoxemia in mice].
abstract: OBJECTIVE
  To determine the anti-inflammatory functions of different cysteine mutants of apolipoprotein A-I recombinant HDLs.
  
  
  METHODS
  The authors reconstituted recombinant HDLs (namely rHDL74, rHDL129, rHDL195 and rHDL228) by mixing wild type or those mutants with dipalmitoyl phosphatidylcholine and examined their in vivo effects upon LPS-induced endotoxemia in mice.
  
  
  RESULTS
  At 24 h post-injection, mice receiving rHDL74 [TNF-alpha: (24 +/- 3) pg/ml; IL-1beta: (45 +/- 5) pg/ml] had a significant decrease of plasma tumor necrosis factor alpha (TNF-alpha) and interleukin-1beta (IL-1beta) as compared with control mice receiving either saline or rHDLwt [TNF-alpha: (135 +/- 12) pg/ml; IL-1beta: (82 +/- 8) pg/ml, P < 0.05]. Administration of rHDL74 to mice injected with LPS also led to a protection of lung against acute injury and attenuation of endotoxin-induced clinical symptoms in mice as compared with controls injected with LPS only.
  
  
  CONCLUSIONS
  Compared with rHDLwt, rHDL74 exhibits higher anti-inflammation capabilities. And it may be a potential clinical candidate for therapy for endotoxin-induced septic shock.
authors.affiliation: Gout Laboratory, Affiliated Hospital of Medical College, Qingdao University, Qingdao 266003, China.
authors.forename: Zhi-min
authors.initials: ZM
authors.lastname: Miao
authors.forename: Shu-lai
authors.initials: SL
authors.lastname: Lu
authors.forename: Chang-gui
authors.initials: CG
authors.lastname: Li
authors.forename: Shi-hua
authors.initials: SH
authors.lastname: Zhao
authors.forename: Sheng-li
authors.initials: SL
authors.lastname: Yan
authors.forename: Yan-gang
authors.initials: YG
authors.lastname: Wang
authors.forename: Lin
authors.initials: L
authors.lastname: Han
authors.forename: Shi-guo
authors.initials: SG
authors.lastname: Liu
authors.forename: Bao-sheng
authors.initials: BS
authors.lastname: Chen
authors.forename: Yun-long
authors.initials: YL
authors.lastname: Wang
mesh_terms: D000818:Animals; D016632:Apolipoprotein A-I / Q000494:pharmacology*; D003545:Cysteine / Q000494:pharmacology*; D019446:Endotoxemia / Q000097:blood*; D053583:Interleukin-1beta / Q000097:blood; D008075:Lipoproteins, HDL / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D050505:Mutant Proteins / Q000494:pharmacology; D011994:Recombinant Proteins / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
chemical_list: D016632:Apolipoprotein A-I; D053583:Interleukin-1beta; D008075:Lipoproteins, HDL; D050505:Mutant Proteins; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D003545:Cysteine